These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38030566)

  • 21. Estimating minimal important differences for several scales assessing function and quality of life in patients with attention-deficit/hyperactivity disorder.
    Hodgkins P; Lloyd A; Erder MH; Setyawan J; Weiss MD; Sasané R; Nafees B
    CNS Spectr; 2017 Feb; 22(1):31-40. PubMed ID: 27535815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADHD in acute care psychiatric inpatients.
    Lines KL; Sadek J
    Atten Defic Hyperact Disord; 2018 Jun; 10(2):129-133. PubMed ID: 29299870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the French Version of the Weiss Functional Impairment Rating Scale-Self-Report in a Large Cohort of Adult Patients With ADHD.
    Micoulaud-Franchi JA; Weibel S; Weiss M; Gachet M; Guichard K; Bioulac S; Philip P; Jaussent I; Dauvilliers Y; Lopez R
    J Atten Disord; 2019 Aug; 23(10):1148-1159. PubMed ID: 30191748
    [No Abstract]   [Full Text] [Related]  

  • 24. Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.
    Nagy P; Häge A; Coghill DR; Caballero B; Adeyi B; Anderson CS; Sikirica V; Cardo E
    Eur Child Adolesc Psychiatry; 2016 Feb; 25(2):141-9. PubMed ID: 25999292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children.
    Nasser A; Liranso T; Adewole T; Fry N; Hull JT; Chowdhry F; Busse GD; Cutler AJ; Jones NJ; Findling RL; Schwabe S
    Clin Ther; 2020 Aug; 42(8):1452-1466. PubMed ID: 32723670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability and validity of the Chinese version of Questionnaire - Children with Difficulties for Chinese children or adolescents with attention-deficit/hyperactivity disorder: a cross-sectional survey.
    Zheng Y; Du Y; Su LY; Zhang Y; Yuan Z; Chen Y; Liu QQ; Ke XY
    Neuropsychiatr Dis Treat; 2018; 14():2181-2190. PubMed ID: 30214208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial.
    Hervas A; Huss M; Johnson M; McNicholas F; van Stralen J; Sreckovic S; Lyne A; Bloomfield R; Sikirica V; Robertson B
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1861-72. PubMed ID: 25453486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Wilens TE; Robertson B; Sikirica V; Harper L; Young JL; Bloomfield R; Lyne A; Rynkowski G; Cutler AJ
    J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):916-25.e2. PubMed ID: 26506582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Attention deficit hyperactivity disorder in children and adolescents].
    Zavadenko NN; Suvorinova NY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(4):29-35. PubMed ID: 32490615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of Achenbach Scales in the Screening of Attention-Deficit/Hyperactivity Disorder in a Community Mental Health Clinic.
    Raiker JS; Freeman AJ; Perez-Algorta G; Frazier TW; Findling RL; Youngstrom EA
    J Am Acad Child Adolesc Psychiatry; 2017 May; 56(5):401-409. PubMed ID: 28433089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Functional Impairments in the Treatment of Children and Adolescents with ADHD.
    Sasser T; Schoenfelder EN; Stein MA
    CNS Drugs; 2017 Feb; 31(2):97-107. PubMed ID: 27943133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spanish validation of the adult Attention Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS): relevance of clinical subtypes.
    Richarte V; Corrales M; Pozuelo M; Serra-Pla J; Ibáñez P; Calvo E; Corominas M; Bosch R; Casas M; Ramos-Quiroga JA
    Rev Psiquiatr Salud Ment; 2017; 10(4):185-191. PubMed ID: 28844652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reformulating attention-deficit/hyperactivity disorder according to signal detection theory.
    Mota VL; Schachar RJ
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1144-51. PubMed ID: 10986811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention and behavioral control skills in Iranian school children.
    Kiani B; Hadianfard H; Mitchell JT
    Atten Defic Hyperact Disord; 2019 Sep; 11(3):263-270. PubMed ID: 30739285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of the Child Behavior Checklist scales for attention-deficit hyperactivity disorder: a receiver-operating characteristic analysis.
    Chen WJ; Faraone SV; Biederman J; Tsuang MT
    J Consult Clin Psychol; 1994 Oct; 62(5):1017-1025. PubMed ID: 7806710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.
    Wietecha L; Williams D; Shaywitz S; Shaywitz B; Hooper SR; Wigal SB; Dunn D; McBurnett K
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):605-13. PubMed ID: 24206099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validity and Reliability of the Turkish Version of the Weiss Functional Impairment Rating Scale- Self Report Form (WFIRSS- TR).
    Yalin-Sapmaz Ş; Ergin D; Şen-Celasin N; Bilaç Ö; Öztürk M; Karaarslan D; Tarakçioğlu MC; Aydemir Ö
    Turk Psikiyatri Derg; 2021; 32(4):261-266. PubMed ID: 34964100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-inserted foreign body and attention-deficit/hyperactivity disorder: evaluated by the Conners' Parent Rating Scales-Revised.
    Özcan K; Özcan Ö; Muluk NB; Cingi C; Durukan K
    Int J Pediatr Otorhinolaryngol; 2013 Dec; 77(12):1992-7. PubMed ID: 24139587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Impairment in Children With Externalizing Behavior Disorders: Psychometric Properties of the Weiss Functional Impairment Rating Scale-Parent Report in a German Clinical Sample.
    Dose C; Hautmann C; Doepfner M
    J Atten Disord; 2019 Nov; 23(13):1546-1556. PubMed ID: 27469396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How much impairment is required for ADHD? No evidence of a discrete threshold.
    Arildskov TW; Sonuga-Barke EJS; Thomsen PH; Virring A; Østergaard SD
    J Child Psychol Psychiatry; 2022 Feb; 63(2):229-237. PubMed ID: 34041741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.